LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.66 USD -2.35% Market Closed
Market Cap: 43.6m USD
Have any thoughts about
LAVA Therapeutics NV?
Write Note

Balance Sheet

Balance Sheet Decomposition
LAVA Therapeutics NV

Current Assets 90.2m
Cash & Short-Term Investments 86.8m
Receivables 1.2m
Other Current Assets 2.2m
Non-Current Assets 2.1m
PP&E 2m
Other Non-Current Assets 144k
Current Liabilities 14.1m
Accounts Payable 4.2m
Accrued Liabilities 4.1m
Short-Term Debt 5.4m
Other Current Liabilities 485k
Non-Current Liabilities 35.3m
Long-Term Debt 295k
Other Non-Current Liabilities 35m

Balance Sheet
LAVA Therapeutics NV

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
7
15
14
90
34
Cash
7
15
14
90
34
Short-Term Investments
0
1
119
43
62
Total Receivables
0
2
1
3
2
Accounts Receivables
0
1
0
3
1
Other Receivables
0
0
0
0
0
Other Current Assets
0
1
3
4
2
Total Current Assets
8
18
137
141
99
PP&E Net
1
2
2
2
2
PP&E Gross
1
2
2
2
2
Accumulated Depreciation
0
0
1
1
2
Other Long-Term Assets
0
1
1
1
0
Total Assets
9
N/A
21
+133%
139
+579%
143
+3%
102
-29%
Liabilities
Accounts Payable
0
1
3
4
4
Accrued Liabilities
1
1
2
8
4
Short-Term Debt
0
0
0
5
5
Current Portion of Long-Term Debt
0
0
0
0
0
Other Current Liabilities
0
5
7
5
0
Total Current Liabilities
1
7
11
22
15
Long-Term Debt
2
4
5
0
1
Other Liabilities
0
2
5
35
35
Total Liabilities
3
N/A
13
+330%
21
+62%
57
+175%
51
-12%
Equity
Common Stock
0
0
4
4
4
Retained Earnings
13
33
74
99
136
Additional Paid In Capital
19
41
192
194
194
Other Equity
0
1
4
13
11
Total Equity
6
N/A
8
+31%
118
+1 458%
86
-27%
51
-40%
Total Liabilities & Equity
9
N/A
21
+133%
139
+579%
143
+3%
102
-29%
Shares Outstanding
Common Shares Outstanding
25
25
26
26
26

See Also

Discover More